Brain tumour clinical trial title
BT-LIFE – Brain Tumours, Lifestyle Interventions, and Fatigue Evaluations (Study ID: 38936)
Brain tumour type
Schwannoma,
Pituitary,
Brain metastases,
Neuroblastoma,
oligoastrocytoma,
Ependymoma,
Meningioma,
Medulloblastoma,
Glioma,
Glioblastoma,
Astrocytoma,
Anaplastic oligodendroglioma,
Anaplastic glioma,
Anaplastic astrocytoma,
Website
www.isrctn.com/ISRCTN17883425
Description:
'BT-LIFE' stands for “Brain Tumours, Lifestyle Interventions, and Fatigue Evaluation." We aim to see if it is feasible to treat fatigue without using drugs, in people who have (or have had) a brain tumour. We are testing two non-drug treatments. The first treatment involves improving lifestyle factors with an intervention called “Health Coachingâ€. The second treatment involves interviews with a trained life coach, called “Patient Activationâ€. These new approaches have a lot of potential to change how we manage fatigue in clinic, if they are feasible to deliver. To answer the question of feasibility we will conduct a feasibility randomised controlled trial in three UK neurooncology centres. A total of 60 participants will be randomised to control (information leaflet), Health Coaching, or Health Coaching + Patient Activation arms. We will monitor recruitment and retention, administer questionnaires, and develop systems that we may use in a future, definitive trial.
Date added:
12th January 2019
Open/Closed:
Open
Trial ends:
August 2019
Provider
Area 159C, 1st Floor
Contact details